World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
38620
World Ranking
15871
National Ranking
79

Overview

Raimund Jakesz is affiliated with the Medical University of Vienna in Austria, contributing to research primarily in the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their work spans multiple important subfields including Cancer Research, Genetics, Oncology, Pathology and Forensic Medicine, and Pulmonary and Respiratory Medicine.

The scientist's research mainly focuses on topics related to breast cancer, with an emphasis on Breast Cancer Treatment Studies, Estrogen and related hormone effects, Breast Lesions and Carcinomas, Advanced Breast Cancer Therapies, and Bone health and treatments. Additional work involves Cancer Cells and Metastasis as well as Bone Metabolism and Diseases.

Jakesz has been involved in several scientific publications, appearing repeatedly in key medical journals. Frequent publication venues include the European Journal of Cancer and Breast Cancer Research and Treatment, with individual contributions also published in the New England Journal of Medicine, NEJM Evidence, and the British Journal of Cancer.

Several recent papers co-authored or involving their collaboration include:

  • Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer, 2021, New England Journal of Medicine
  • Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34), 2020, European Journal of Cancer
  • Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial, 2020, European Journal of Cancer
  • Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer, 2022, NEJM Evidence
  • Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34, 2021, British Journal of Cancer

Throughout their career, Raimund Jakesz has collaborated frequently with several co-authors, including Michael Gnant, Richard Greil, Florian Fitzal, Marija Balić, and Christian F. Singer. These partnerships highlight an active engagement in multidisciplinary cancer research teams.

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

    Michael Gnant;Brigitte Mlineritsch;Walter Schippinger;Gero Luschin-Ebengreuth

  • Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

    Raimund Jakesz;Walter Jonat;Michael Gnant;Martina Mittlboeck

  • Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

    Mitch Dowsett;Jack Cuzick;Jim Ingle;Alan Coates

  • Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Bernard Asselain;William Barlow;John Bartlett;Jonas Bergh

  • A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

    Martin Filipits;Margaretha Rudas;Raimund Jakesz;Peter Dubsky

  • Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial

    Michael Gnant;Brigitte Mlineritsch;Herbert Stoeger;Gero Luschin-Ebengreuth

  • Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo- controlled trial

    Michael Gnant;Georg Pfeiler;Peter C Dubsky;Michael Hubalek

  • Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer

    Monika Schindl;Sebastian F. Schoppmann;Hellmut Samonigg;Hubert Hausmaninger

  • Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

    J Cuzick;L Ambroisine;N Davidson;R Jakesz

  • Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

    Michael Gnant;Brigitte Mlineritsch;Gero Luschin-Ebengreuth;Franz Kainberger

  • Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

    M. Gnant;M. Filipits;R. Greil;H. Stoeger

  • Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group

    Michael F.X. Gnant;Brigitte Mlineritsch;Gero Luschin-Ebengreuth;Stephan Grampp

  • TP53 Mutation and p53 Overexpression for Prediction of Response to Neoadjuvant Treatment in Breast Cancer Patients

    Daniela Kandioler-Eckersberger;Carmen Ludwig;Margarethe Rudas;Sonja Kappel

  • The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients

    P Dubsky;J C Brase;R Jakesz;M Rudas

  • Randomized Adjuvant Trial of Tamoxifen and Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil: Evidence for the Superiority of Treatment With Endocrine Blockade in Premenopausal Patients With Hormone-Responsive Breast Cancer—Austrian Breast and Colorectal Cancer Study Group Trial 5

    Raimund Jakesz;Hubert Hausmaninger;Ernst Kubista;Michael Gnant

  • Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer

    Sebastian F. Schoppmann;Guenther Bayer;Klaus Aumayr;Susanne Taucher

  • Extended Adjuvant Therapy With Anastrozole Among Postmenopausal Breast Cancer Patients: Results From the Randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a

    Raimund Jakesz;Richard Greil;Michael Gnant;Marianne Schmid

  • Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

    M. Gnant;B. Mlineritsch;H. Stoeger;G. Luschin-Ebengreuth

  • Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis

    Walter Jonat;Michael Gnant;Francesco Boccardo;Manfred Kaufmann

Frequent Co-Authors

Michael Gnant
Michael Gnant Medical University of Vienna
Richard Greil
Richard Greil Paracelsus Medical University
Christian F. Singer
Christian F. Singer Medical University of Vienna
Christoph C. Zielinski
Christoph C. Zielinski Medical University of Vienna
Christian Marth
Christian Marth Innsbruck Medical University
Nadia Harbeck
Nadia Harbeck Ludwig-Maximilians-Universität München
John Crown
John Crown Dublin City University
Christoph Thomssen
Christoph Thomssen University of Göttingen
Jonas Bergh
Jonas Bergh Karolinska Institute
Marc Buyse
Marc Buyse Hasselt University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their career options in the medical and healthcare field, a range of related online degrees can provide additional pathways. Many choose to pursue advanced education in management, nursing, pharmacy, or health information to open up new roles or leadership positions.

If you are drawn to the administrative side of healthcare, consider exploring the cheapest online mha programs. These programs offer affordable opportunities to develop expertise in healthcare administration while maintaining flexibility.

Registered nurses looking to advance into leadership, education, or specialized nursing roles might benefit from msn to dnp programs online. Doctor of Nursing Practice degrees can help nurses move into higher clinical or executive positions.

For those interested in the pharmaceutical side of medicine, there are now online pharmacist programs designed for flexibility and affordability. Graduates can pursue careers in clinical pharmacy, research, or industry settings.

Additionally, the growing field of healthcare data and records management is supported by online schools for health information management. These programs train students to manage and protect essential medical information, a critical role in modern healthcare systems.

Best Scientists Citing Raimund Jakesz

Trending Scientists